Cochlear | COH - Assets


Cochlear reported AUD2.79B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Ansell USD 3.33B 3.2M Dec/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Fisher Paykel Healthcare NZD 2.85B 222.3M Jun/2026
Healius AUD 3.07B 84.2M Dec/2024
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Mayne Pharma AUD 1.14B 9.47M Jun/2024
Mesoblast USD 773.08M 9.23M Jun/2026
Monash IVF AUD 510.21M 17.6M Dec/2025
Nanosonics AUD 279.25M 6.77M Dec/2025
Polynovo AUD 123.37M 4.04M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
Regis Healthcare AUD 2.6B 494.01M Dec/2025
ResMed USD 8.78B 280.91M Mar/2026
Sigma Healthcare AUD 8.29B 6.91B Dec/2025
Somnomed AUD 62.49M 2.16M Jun/2023
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Telix Pharmaceuticals AUD 1.36B 197.86M Jun/2026